Sugi Predict

Sugi Predict / Compounds / SCHEMBL2170533

SCHEMBL2170533

SCHEMBL2170533

CC1(C)C(=O)N(C2C3CC4CC(C3)CC2C4)N1C(=O)c1cc(Cl)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CXCR3 P49682 5/20 0.38
▸ HSD11B1 P28845 2/20 0.34
▸ HSD11B2 P80365 1/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ HPGD P15428 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPBWR1 P48145 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ EPHX2 P34913 2/20 0.32
▸ MGLL Q99685 1/20 0.32
▸ P2RX7 Q99572 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ GAA P10253 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2171870 0.90 TP53 (0.41) HSD11B1HSD11B2ALDH1A1KDM4EP2RX7
SCHEMBL2170598 0.90 CES2 (0.36) ALDH1A1EPHX2KMT2AGAA
SCHEMBL13368764 0.89 HCRTR1 (0.40) CXCR3HSD11B1HSD11B2ALDH1A1HPGD
SCHEMBL2170032 0.88 HSD11B1 (0.33) CXCR3HSD11B1HSD11B2ALDH1A1HPGD
SCHEMBL2169004 0.88 P2RX7 (0.40) CXCR3P2RX7KMT2A
SCHEMBL2169957 0.85 EPHX2 (0.39) ALDH1A1KDM4EEPHX2KMT2A
SCHEMBL2169753 0.83 P2RX7 (0.42) HSD11B1ALDH1A1HPGDKDM4EP2RX7
SCHEMBL2169955 0.83 CPS1 (0.36) KDM4EEPHX2KMT2A
SCHEMBL2169179 0.82 KMT2A (0.39) ALDH1A1HPGDMGLLP2RX7KMT2A
SCHEMBL2169415 0.81 P2RX7 (0.36) HSD11B1HPGDEPHX2MGLLP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252781-B2 1,2-diazetidin-3-one derivatives and drugs containing same KOWA COMPANY, LTD. (JP) 2012-08-28 — — US disclosed
US-8252781-B2 1,2-diazetidin-3-one derivatives and drugs containing same KOWA COMPANY, LTD. (JP) 2012-08-28 — — US disclosed
US-8252781-B2 1,2-diazetidin-3-one derivatives and drugs containing same KOWA COMPANY, LTD. (JP) 2012-08-28 — — US disclosed
EP-2348019-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME Kowa Company, Ltd. (JP) 2011-07-27 — — EP disclosed
EP-2348019-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME Kowa Company, Ltd. (JP) 2011-07-27 — — EP disclosed
US-20100144694-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME KOWA COMPANY, LTD. (JP) 2010-06-10 — — US disclosed
US-20100144694-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME KOWA COMPANY, LTD. (JP) 2010-06-10 — — US disclosed
US-20100144694-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME KOWA COMPANY, LTD. (JP) 2010-06-10 — — US disclosed
WO-2010050191-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME 興和株式会社 (JP) 2010-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144694-A1 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 CXCR3 3206/4885HSD11B1 1/4885HSD11B2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.